Macromolecular drugs are very promising as improved therapeutics for numerous serious disorders such as cancer and cardiovascular disease. A full understanding of the 3-D structure and possibly the function of a macromolecule is needed to develop efficient, safe and specific delivery mechanisms. 3-D holographic imaging is the key to this.
We specialize in laser development, for macromolecular drug development.
There are only four facilities worldwide, operational or being built at a cost of hundreds of millions of dollars, that provide a step towards this capability.
Our laser offers advances in the area of X-ray holography for the time resolved capability of measuring the 3-D change of a molecule subject to some sort of stimulus – i.e. laser output. At a cost in the millions of dollars, a two orders of magnitude reduction on current technology, macromolecular research and development will be affordable to research organizations, universities, and across the BioPharma and pharmaceutical industries.
Contact us to find out more.